Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$499M |
| 2 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$479M |
| 3 |
Merck
MRK
|
+$328M |
| 4 |
BAY
BAYER AG SPONS ADR
BAY
|
+$287M |
| 5 |
Lloyds Banking Group
LYG
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$958M |
| 2 |
IBM
IBM
|
+$565M |
| 3 |
McDonald's
MCD
|
+$502M |
| 4 |
CSE
CAPITALSOURCE INC
CSE
|
+$95.8M |
| 5 |
PL
PROTECTIVE LIFE CORP
PL
|
+$66.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.81% |
| 2 | Healthcare | 13.89% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
ScottsMiracle-Gro
SMG
$3.97B
| $85.1M | 0.18% |
1,496,293
-19,515
| -1% | -$1.17M |
|
77
Steris
STE
$22.5B
| $84.9M | 0.18% |
1,586,711
-25,145
| -2% | -$1.29M |
|
|
EMBJ
78
Embraer S.A. ADS
EMBJ
$12.1B
| $84.5M | 0.18% |
2,320,868
+392,294
| +20% | +$13.8M |
|
79
Raymond James Financial
RJF
$33.6B
| $84.2M | 0.18% |
2,490,705
-14,703
| -0.6% | -$491K |
|
|
KSU
80
DELISTED
Kansas City Southern
KSU
| $83.6M | 0.18% |
777,928
-179
| -0% | -$18.5K |
|
|
FEIC
81
DELISTED
FEI COMPANY
FEIC
| $83.3M | 0.18% |
918,041
-942
| -0.1% | -$83K |
|
|
FNSR
82
DELISTED
Finisar Corp
FNSR
| $83.1M | 0.17% |
4,208,399
-182,155
| -4% | -$4.38M |
|
|
FBG
83
DELISTED
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
| $81.8M | 0.17% |
1,630,403
-20,153,182
| -93% | -$958M |
|
|
BID
84
DELISTED
Sotheby's
BID
| $81.6M | 0.17% |
1,942,768
-16,890
| -0.9% | -$688K |
|
|
JAH
85
DELISTED
JARDEN CORPORATION
JAH
| $81.2M | 0.17% |
2,051,981
-53,362
| -3% | -$2.03M |
|
86
Gilead Sciences
GILD
$163B
| $80.9M | 0.17% |
975,483
+373,725
| +62% | +$29.1M |
|
|
CADE
87
DELISTED
Cadence Bank
CADE
| $80.7M | 0.17% |
3,283,048
-86,685
| -3% | -$2.06M |
|
88
Veeco
VECO
$2.95B
| $80.1M | 0.17% |
2,150,726
-245,256
| -10% | -$8.76M |
|
|
JNS
89
DELISTED
Janus Capital Group Inc
JNS
| $78.1M | 0.16% |
6,258,561
-183,520
| -3% | -$2.16M |
|
|
FMER
90
DELISTED
FIRSTMERIT CORP
FMER
| $77.4M | 0.16% |
3,921,477
+506,970
| +15% | +$9.92M |
|
|
AXE
91
DELISTED
Anixter International Inc
AXE
| $76.2M | 0.16% |
761,826
-17,342
| -2% | -$1.71M |
|
|
WMGI
92
DELISTED
Wright Medical Group Inc
WMGI
| $75M | 0.16% |
2,389,299
-23,180
| -1% | -$692K |
|
93
HUB Group
HUBG
$2.78B
| $74.7M | 0.16% |
2,962,994
+76,834
| +3% | +$1.75M |
|
94
Lincoln Electric
LECO
$13.7B
| $74.5M | 0.16% |
1,066,315
-18,172
| -2% | -$1.23M |
|
|
HPY
95
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $74.4M | 0.16% |
1,804,204
+55,284
| +3% | +$2.25M |
|
96
Canadian National Railway
CNI
$76.9B
| $73.3M | 0.15% |
1,127,110
+483,064
| +75% | +$28.7M |
|
97
Boston Beer
SAM
$1.93B
| $72.8M | 0.15% |
325,872
-5,657
| -2% | -$1.29M |
|
|
AEL
98
DELISTED
American Equity Investment Life Holding Company
AEL
| $72.5M | 0.15% |
2,947,520
-62,295
| -2% | -$1.44M |
|
|
OUTR
99
DELISTED
OUTERWALL INC
OUTR
| $71.7M | 0.15% |
1,207,687
-31,774
| -3% | -$2.15M |
|
100
Perrigo
PRGO
$1.43B
| $70.9M | 0.15% |
486,226
+2,366
| +0.5% | +$335K |
|
Similar funds
Ken Fisher's Q2 2014 Portfolio in Review
As of Q2 2014, Ken Fisher held 668 positions worth $47.6B, up 7.3% from $44.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher deployed $2.03B of net new capital in Q2 2014, opening 82 new positions and adding to 273 existing holdings. Its largest new stake was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, an estimated $958M trimmed.
- Ken Fisher's largest Q2 2014 buy was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
- Ken Fisher added most to Merck in Q2 2014, an estimated $328M increase.
- Ken Fisher's biggest Q2 2014 reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, cutting an estimated $958M.
- Ken Fisher fully exited CAPITALSOURCE INC in Q2 2014, selling an estimated $95.8M.
- Ken Fisher's ten largest holdings make up 23% of its $47.6B portfolio in Q2 2014.
- Ken Fisher opened 82 new positions and closed 70 in Q2 2014.
- Ken Fisher's portfolio value rose 7.3% quarter-over-quarter to $47.6B.
Based on Fisher Asset Management's 13F filing for Q2 2014, filed 25 Jul 2014.